The Role of Immunosuppression in Malignancies Among 351 Pediatric Renal Transplant Patients

Transplantation Proceedings

Volumn 42, Issue 4, 2010, Pages 1166-1168

  Berardinelli, L ^a   Raiteri, M ^a   Ghio, L ^a   Messa, P G ^a   Montagnino, G ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CALCINEURIN INHIBITOR; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CANCER INCIDENCE; CANCER RECURRENCE; CANCER RISK; CHILD; CHILDHOOD CANCER; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; GRAFT SURVIVAL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ARTERY EMBOLIZATION; KIDNEY CANCER; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RETRANSPLANTATION; RISK FACTOR; SURVIVAL RATE;

ADOLESCENT; AGE OF ONSET; CADAVER; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOSUPPRESSION; INFANT; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; NEOPLASMS; RETROSPECTIVE STUDIES; RISK FACTORS; TISSUE DONORS;

EID: 77952571583     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2010.03.131     Document Type: Article

References (12)

1. Sheil A.G.R., Disney A.P.S., Mathew T.H., et al. Lymphoma incidence, cyclosporine, and the evolution and major impact of malignancy following organ transplantation. Transplant Proc 29 (1997) 825
2. Neuzillet Y., Lay F., Luccioni A., et al. De novo renal cell carcinoma of native kidney in renal transplant recipients. Cancer 103 (2005) 251
3. Kausman J.Y., Somers G.R., Francis D.M., et al. Association of renal adenocarcinoma and BK virus nephropathy post transplantation. Pediatr Nephrol 19 (2004) 459
4. Emerson L.L., Carney H.M., Layfield L.J., et al. Collecting duct carcinoma arising in association with BK nephropathy post-transplantation in a pediatric patient. A case report with immunohistochemical and in situ hybridization study. Pediatr Transplantation 12 (2008) 600
5. Nocera A., Ghio L., Dall'Amico R., et al. De novo cancers in paediatric renal transplant recipients: a multicentre analysis within the North Italy Transplant programme (NITp), Italy. Eur J Cancer 36 (2000) 80
6. Cockfield S.M., Preiksaitis J.K., Jewell L.D., et al. Post-transplant lymphoproliferative disorder in renal allograft recipients. Clinical experience and risk factor analysis in a single center. Transplantation 56 (1993) 88
7. Ciancio G., Siquijor A.P., Burke G.W., et al. Post-transplant lymphoproliferative disease in kidney transplant patients in the new immunosuppressive era. Clin Transplant 11 (1997) 243
8. Mihalov M.L., Gattuso P., Abraham K., et al. Incidence of post-transplant malignancy among 674 solid-organ-transplant recipients at a single center. Clin Transplant 10 (1996) 248
9. Dharnidharka V.R., Sullivan E.K., Stablein D.M., et al. Risk factors for post transplant lymphoproliferative disorder (PTLD) in pediatric kidney transplantation. A report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). Transplantation 71 (2001) 1065
10. Alexander S.R., Arbus G.S., Butt K.M., et al. The 1989 report of the North American Pediatric Renal Transplant Cooperative Study. Pediatr Nephrol 4 (1990) 542
11. Berardinelli L., Messa P.G., Pozzoli E., et al. Malignancies in 2,753 kidney recipients transplanted during a 39-year experience. Transplant Proc 41 (2009) 1231
12. Mehls O., Wilton P., Lilien M., et al. Does growth hormone treatment affect the risk of post-transplant renal cancer?. Pediatr Nephrol 17 (2002) 984